Stocks
Cancer care's next chapter
Big pharma is eyeing the future.
Follow pharma stocks, biotech, medical devices, clinical trials, and healthcare policy developments moving health sector equities.
Big pharma is eyeing the future.
Eli wins this round, while Novo continues to flounder.
Shares sank on the news.
The end of the government shutdown is the beginning of problems for healthcare stocks.
The two pharma companies are duking it out for the future of weight-loss drugs.
President Trump's unplanned remarks took a toll on Novo Nordisk and Eli Lilly.
Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.
By subscribing, you accept our Terms & Privacy Policy.